We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Black Diamond Therapeutics
BDTX
$112M
| $2.07M | ﹤0.01% |
49,111
+13,047
| +36% | +$480K |
|
|
VRS
2327
DELISTED
Verso Corporation
VRS
| $2.07M | ﹤0.01% |
173,061
+958
| +0.6% | +$12.5K |
|
2328
Castle Biosciences
CSTL
$979M
| $2.07M | ﹤0.01% |
54,840
-9,625
| -15% | -$329K |
|
2329
Gorman-Rupp
GRC
$2.21B
| $2.06M | ﹤0.01% |
66,410
-25,498
| -28% | -$747K |
|
2330
OrthoPediatrics
KIDS
$595M
| $2.06M | ﹤0.01% |
47,134
+5,092
| +12% | +$229K |
|
2331
Resources Connection
RGP
$145M
| $2.06M | ﹤0.01% |
172,169
+14,492
| +9% | +$157K |
|
|
FRG
2332
DELISTED
Franchise Group, Inc.
FRG
| $2.05M | ﹤0.01% |
+93,644
| New | +$1.49M |
|
2333
A10 Networks
ATEN
$1.95B
| $2.03M | ﹤0.01% |
298,063
-127,654
| -30% | -$857K |
|
|
ASAP
2334
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $2.02M | ﹤0.01% |
+38,301
| New | +$1.47M |
|
2335
Covenant Logistics
CVLG
$872M
| $2.01M | ﹤0.01% |
279,152
+15,040
| +6% | +$76.7K |
|
|
DRRX
2336
DELISTED
DURECT Corp
DRRX
| $2.01M | ﹤0.01% |
+86,773
| New | +$1.91M |
|
2337
CEL-SCI Corp
CVM
$30.1M
| $2.01M | ﹤0.01% |
4,487
-74
| -2% | -$30.4K |
|
|
NVEE
2338
DELISTED
NV5 Global
NVEE
| $2.01M | ﹤0.01% |
158,048
-5,360
| -3% | -$60.3K |
|
|
AGEN
2339
Agenus
AGEN
$290M
| $2.01M | ﹤0.01% |
26,022
-715
| -3% | -$42.8K |
|
2340
Modine Manufacturing
MOD
$10.4B
| $2.01M | ﹤0.01% |
363,586
-210,169
| -37% | -$965K |
|
|
ANAT
2341
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2M | ﹤0.01% |
27,829
-2,734
| -9% | -$204K |
|
|
QTNT
2342
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2M | ﹤0.01% |
+6,773
| New | +$1.95M |
|
|
CFB
2343
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $2M | ﹤0.01% |
204,764
+17,361
| +9% | +$159K |
|
|
DCOM
2344
DELISTED
Dime Community Bancshares
DCOM
| $1.99M | ﹤0.01% |
145,244
-1,081
| -0.7% | -$15.7K |
|
2345
National Presto Industries
NPK
$989M
| $1.98M | ﹤0.01% |
22,667
+2,656
| +13% | +$226K |
|
|
NWLI
2346
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.98M | ﹤0.01% |
9,730
+880
| +10% | +$168K |
|
2347
Luxfer Holdings
LXFR
$458M
| $1.98M | ﹤0.01% |
+139,636
| New | +$1.93M |
|
|
ARCH
2348
DELISTED
Arch Resources, Inc.
ARCH
| $1.97M | ﹤0.01% |
69,217
+8,371
| +14% | +$260K |
|
2349
Great Southern Bancorp
GSBC
$878M
| $1.96M | ﹤0.01% |
48,679
-8,553
| -15% | -$338K |
|
2350
Zentalis Pharmaceuticals
ZNTL
$302M
| $1.94M | ﹤0.01% |
+40,464
| New | +$1.55M |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.